
Alzheimer’s: Delhi pharma company gets Bengaluru scientists’ drug candidate
Hamsa Biopharma, which will take the drug — Christened TGR63 — to trials through its parent company in the US, IGC Pharma, hopes it can eventually be made available in the market.